Earnings Scheduled For February 2, 2022
Companies Reporting Before The Bell
• Sony Group (NYSE:SONY) is likely to report quarterly earnings at $1.57 per share on revenue of $24.59 billion.
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
The broader market weakness pervaded into the biotech sector in the week ending Jan. 28, sending stocks lower.
SVB Leerink Maintains Market Perform on Arrowhead Pharmaceuticals, Raises Price Target to $46
SVB Leerink analyst Mani Foroohar maintains Arrowhead Pharmaceuticals (NASDAQ:ARWR) with a Market Perform and raises the price target from $45 to $46.
Goldman Sachs Upgrades Arrowhead Pharmaceuticals to Buy
Goldman Sachs analyst Madhu Kumar upgrades Arrowhead Pharmaceuticals (NASDAQ:ARWR) from Neutral to Buy.
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.
Watching Arrowhead Pharmaceuticals Shares; Zacks Small-Cap Research Sets $100 Valuation
https://s27.q4cdn.com/906368049/files/News/2021/Zacks_SCR_Research_12062021_ARWR_Bautz.pdf
ARWR: License Agreement with GSK for ARO-HSD
By David Bautz, PhD
NASDAQ:ARWR
READ THE FULL ARWR RESEARCH REPORT
GlaxoSmithKline Pens $1B Pact For NASH Candidate With Arrowhead
Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR)
SVB Leerink Maintains Market Perform on Arrowhead Pharmaceuticals, Raises Price Target to $45
SVB Leerink analyst Mani Foroohar maintains Arrowhead Pharmaceuticals (NASDAQ:ARWR) with a Market Perform and raises the price target from $44 to $45.